ICCC vs ZBRA · rev $17.5M vs P/E 28, rev $3.05B
ImmuCell Corporation (ICCC) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
ICCC currently screens at market cap $58.9M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the ICCC and ZBRA stock pages for the full models.
Not investment advice.